Companies / Ionis Pharmaceuticals Inc / Activity
Activity — Ionis Pharmaceuticals Inc
251 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Baroldi Joseph Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Mar 10, 2026 | Jenne Kyle Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -33K -50.00% | 32,601 0.02% of shares | low |
| Mar 10, 2026 | Jenne Kyle Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -5K -25.00% | 14,025 <0.01% of shares | low |
| Jan 15, 2026 | Jenne Kyle Executive | Exercise | Restricted Stock Unit | — | -7K -19.12% | 29,664 0.02% of shares | low |
| Jan 15, 2026 | Jenne Kyle Executive | Grant | Restricted Stock Unit | — | +10K +34.49% | 37,725 0.02% of shares | low |
| Jan 15, 2026 | Jenne Kyle Executive | Grant | Performance Restricted Stock Units | — | +26K +137.97% | 44,500 0.03% of shares | low |
| Jan 2, 2026 | Jenne Kyle Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Grant | Restricted Stock Unit | — | +225 +58.29% | 611 <0.01% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Exercise | Restricted Stock Unit | — | -111 -22.33% | 386 <0.01% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Grant | Restricted Stock Unit | — | +10K +24.65% | 48,926 0.03% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Exercise | Restricted Stock Unit | — | -21K -35.25% | 39,251 0.02% of shares | low |
| Jan 15, 2026 | Swayze Eric Executive | Grant | Performance Restricted Stock Units | — | +26K +40.01% | 90,282 0.05% of shares | low |
| Jan 2, 2026 | Swayze Eric Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +150 | 150 <0.01% of shares | low |
| Jan 2, 2026 | Swayze Eric Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Jan 2, 2026 | Swayze Eric Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -18K -81.86% | 4,065 <0.01% of shares | low |
| Jan 2, 2026 | Swayze Eric Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -5K -18.62% | 22,403 0.01% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -18K -100.00% | 0 0.00% of shares | low |
| Mar 3, 2026 | Diaz Allene M. Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| Jan 15, 2026 | Yang Michael J. Director | Exercise | Restricted Stock Unit | — | -2K -21.26% | 7,150 <0.01% of shares | low |
| Jan 15, 2026 | O'Neil Patrick R. Executive | Grant | Restricted Stock Unit | — | +10K +24.65% | 48,926 0.03% of shares | low |
| Jan 15, 2026 | O'Neil Patrick R. Executive | Exercise | Restricted Stock Unit | — | -21K -35.36% | 39,251 0.02% of shares | low |
| Jan 15, 2026 | O'Neil Patrick R. Executive | Grant | Performance Restricted Stock Units | — | +26K +39.81% | 90,601 0.05% of shares | low |
| Jan 2, 2026 | O'Neil Patrick R. Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,350 0.01% of shares | low |
| Mar 10, 2026 | Monia Brett P CEO | Exercise | Non-Qualified Stock Option (right to buy) | — | -34K -100.00% | 0 0.00% of shares | low |
| Mar 9, 2026 | Monia Brett P CEO | Exercise | Non-Qualified Stock Option (right to buy) | — | -74K -68.32% | 34,103 0.02% of shares | low |
| Mar 9, 2026 | Monia Brett P CEO | Exercise | Non-Qualified Stock Option (right to buy) | — | -41K -27.50% | 107,632 0.06% of shares | low |
| Jan 15, 2026 | Monia Brett P CEO | Grant | Restricted Stock Unit | — | +43K +26.20% | 205,719 0.12% of shares | low |
| Jan 15, 2026 | Monia Brett P CEO | Exercise | Restricted Stock Unit | — | -89K -35.35% | 163,014 0.10% of shares | low |
| Jan 15, 2026 | Monia Brett P CEO | Grant | Performance Restricted Stock Units | — | +114K +18.07% | 744,081 0.45% of shares | low |
| Jan 2, 2026 | Monia Brett P CEO | Grant | Non-Qualified Stock Option (right to buy) | — | +85K | 85,410 0.05% of shares | low |
| Mar 4, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -200 -1.79% | 10,968 <0.01% of shares | low |
| Mar 3, 2026 | Loscalzo Joseph Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -832 -6.93% | 11,168 <0.01% of shares | low |
| Mar 3, 2026 | Klein Joseph III Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 3, 2026 | Klein Joseph III Director | Exercise | Non-Qualified Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -60K -100.00% | 0 0.00% of shares | low |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -61K -100.00% | 0 0.00% of shares | low |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -21K -79.17% | 5,405 <0.01% of shares | low |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -33K -100.00% | 0 0.00% of shares | low |
| Jan 15, 2026 | Hougen Elizabeth L Executive | Grant | Restricted Stock Unit | — | +13K +23.03% | 68,825 0.04% of shares | low |
| Jan 15, 2026 | Hougen Elizabeth L Executive | Exercise | Restricted Stock Unit | — | -29K -33.93% | 55,940 0.03% of shares | low |
| Jan 15, 2026 | Hougen Elizabeth L Executive | Grant | Performance Restricted Stock Units | — | +34K +39.66% | 120,995 0.07% of shares | low |
| Jan 2, 2026 | Hougen Elizabeth L Executive | Grant | Non-Qualified Stock Option (right to buy) | — | +26K | 25,770 0.02% of shares | low |
| Mar 3, 2026 | Bennett C Frank Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -49K -100.00% | 0 0.00% of shares | low |
| Mar 3, 2026 | Bennett C Frank Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -16K -87.25% | 2,406 <0.01% of shares | low |
| Feb 2, 2026 | Bennett C Frank Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -49K -100.00% | 0 0.00% of shares | low |
| Feb 2, 2026 | Bennett C Frank Executive | Exercise | Non-Qualified Stock Option (right to buy) | — | -16K -87.25% | 2,406 <0.01% of shares | low |
| Jan 15, 2026 | Bennett C Frank Executive | Grant | Restricted Stock Unit | — | +10K +55.50% | 27,109 0.02% of shares | low |
| Jan 15, 2026 | Bennett C Frank Executive | Exercise | Restricted Stock Unit | — | -21K -54.70% | 17,434 0.01% of shares | low |
| Jan 15, 2026 | Bennett C Frank Executive | Grant | Performance Restricted Stock Units | — | +26K +40.64% | 89,282 0.05% of shares | low |